Oncology & Cancer

FDA approves novel treatment for hairy cell leukemia

(HealthDay)—Lumoxiti (moxetumomab pasudotox-tdfk) injection has been approved to treat certain instances of relapsed or refractory hairy cell leukemia (HCL), the U.S. Food and Drug Administration said yesterday.

Diseases, Conditions, Syndromes

Guidance provided for reporting foodborne illness

(HealthDay)—The U.S. Centers for Disease Control and Prevention offers guidance for health care professionals on reporting foodborne illnesses.

Diseases, Conditions, Syndromes

Maine expanding probe into E. coli after 1-year-old boy dies

Maine public health authorities confirmed Friday that one child—identified by his father as a 20-month-old boy from the town of Poland—has died and another was hospitalized after both attended a county fair and then showed ...


Certain mutations affect kidney disease risk and prognosis

Certain gene mutations affect individuals' risk of developing a serious kidney condition, as well as their prognosis after being diagnosed with the disease, according to a study appearing in an upcoming issue of the Journal ...

page 1 from 3